Header Logo

Connection

David Becker to Disease Models, Animal

This is a "connection" page, showing publications David Becker has written about Disease Models, Animal.
Connection Strength

0.066
  1. Diagnostic and therapeutic applications of azulenyl nitrone spin traps. Cell Mol Life Sci. 1999 Nov 15; 56(7-8):626-33.
    View in: PubMed
    Score: 0.029
  2. Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window. Brain Res. 2007 Nov 14; 1180:101-10.
    View in: PubMed
    Score: 0.012
  3. Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia. Ann Neurol. 2003 Sep; 54(3):330-42.
    View in: PubMed
    Score: 0.009
  4. Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats. J Neurosurg. 2002 Jun; 96(6):1077-83.
    View in: PubMed
    Score: 0.009
  5. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol. 1998 Nov; 44(5):763-70.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.